Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALPINE-SVG
NCT01221402Phase 2Completed
- Sponsor
- VA North Texas Health Care System
- Start
- Oct 2010
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of niacin in saphenous vein graft atherosclerosis, sponsored by VA North Texas Health Care System. Started Oct 2010; status: completed.
02
Drugs
niacin
03
Conditions
saphenous vein graft atherosclerosis
Beyond the preview
Go deeper on NCT01221402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01221402.